A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France
A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France
Clinical, biological, radiological, and pharmacological description of cases of disseminated borreliosis (Borrelia burgdorferi sl. and Borrelia miyamotoi) occurring in patients who received drug treatment based on anti-CD20 monoclonal antibodies.
Inclusion Criteria:
Exclusion Criteria:
- Refusal to participate in the study
pierre.boyer@chru-strasbourg.fr33 3 69 55 14 69
Strasbourg, 67091, France
pierre.boyer@chru-strasbourg.fr33 3 69 55 14 69
Emilie.TALAGRANDREBOUL@chru-strasbourg.fr33 3 69 55 14 57